Annapolis Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$18.5K Hold
161
0.01% 228
2024
Q2
$17.1K Hold
161
0.01% 230
2024
Q1
$15.6K Hold
161
0.01% 237
2023
Q4
$16.3K Hold
161
﹤0.01% 301
2023
Q3
$16.4K Hold
161
﹤0.01% 288
2023
Q2
$16.2K Hold
161
﹤0.01% 292
2023
Q1
$14.8K Hold
161
﹤0.01% 275
2022
Q4
$14.6K Sell
161
-39
-20% -$3.29K ﹤0.01% 268
2022
Q3
$15K Buy
+200
New +$16.6K 0.01% 291
2021
Q4
Sell
-45
Closed -$4K 493
2021
Q3
$4K Hold
45
﹤0.01% 357
2021
Q2
$4K Hold
45
﹤0.01% 335
2021
Q1
$4K Hold
45
﹤0.01% 319
2020
Q4
$4K Buy
+45
New +$3.93K ﹤0.01% 320

Other funds holding NVS

Annapolis Financial Services's NVS Position: Q3 2024 in Review

Annapolis Financial Services held its Novartis (NVS) position steady in Q3 2024 at 161 shares worth $18.5K. The position accounts for 0.01% of the portfolio, ranked #228.

Annapolis Financial Services first reported a position in NVS in Q4 2020 and has held it in 13 quarters since. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • Annapolis Financial Services held 161 shares of Novartis worth $18.5K as of Q3 2024.
  • Annapolis Financial Services left its Novartis share count unchanged in Q3 2024.
  • Novartis made up 0.01% of Annapolis Financial Services's portfolio in Q3 2024, its #228 holding.
  • Annapolis Financial Services first reported a position in Novartis in Q4 2020 and has held it in 13 quarters since.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Annapolis Financial Services's 13F filing for Q3 2024, filed 16 Oct 2024.